Kim M. Bonner

I am a highly skilled and dynamic clinical development professional and comparative pathologist possessing 18 years of diverse international experience and multi-therapeutic acumen coupled with a proven ability to drive complex preclinical and clinical development programs to achieve business imperatives. I possess a diverse, global industry skillset gained in venture capital funded start-ups, biopharmaceutical organizations and CROs, encompassing all stages of preclinical and clinical drug development and commercialization including AI-based drug development. I am a goal- orientated strategic thinker with a passion for leadership and demonstrated ability to manage high performing cross-functional teams in a high paced environment. I have highly regarded interpersonal skills with exceptional communication, organizational and presentation capabilities. Companies that would most benefit from my expertise include SMID biotech companies and biotechnology companies seeking expertise in AI-based drug development.

My areas of expertise include:

OPERATIONAL EXPERTISE:
- Preclinical & Clinical Development Plans
- Global Asset Development Strategy and Tactical Planning
- Budget and Resource Management
- CRO Strategic Management and Selection
- Risk Assess/Mgt Global Regulatory Submissions and Launch

THERAPEUTIC EXPERTISE:
- Oncology
- Hematological Oncology
- Immunotherapy
- Neurodegenerative Disease & CNS
- Preclinical Toxicological Pathology Comparative & Investigative Pathology
- AI based Drug Development
- Biomarker & Translational Laboratory Strategy